This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
10-07/08 :: July/August 2010


nanotimes


Companies Facts


“We are pleased to have successfully achieved this critical round of financing,” said CEO of Modumetal, Christina Lomasney. “The entire Modumetal team is looking forward to leveraging Mr. Silverman’s insight and experience to move our venture forward into a critical stage of sales growth and production scale- up.”


Modumetal of Seattle, WA, USA, founded in 2007, is realizing the commercial potential of a unique class of nano-laminated materials. Modumetal™ is a revolutionary nanolaminated alloy that is stronger and lighter than steel and will replace conventional metals and composites in many applications. http://www.modumetal.com


M


olycorp Minerals, LLC (NYSE: MCP), a wholly owned subsidiary of Molycorp, Inc. and the


owner of the largest non-Chinese rare earth depo- sit in the world, and Neo Material Technologies Inc. (TSX: NEM), a global producer of neodymium- iron-boron magnetic powders and rare-earth-based engineered materials and applications, have entered into a letter of intent pursuant to which the two com- panies expect to cooperate in the rare earth “Mine to Magnets” supply chain to their mutual benefit.


The letter of intent contemplates a technology trans- fer agreement between the companies pursuant to which Neo would provide Molycorp with technical assistance and know-how with respect to production of rare earth metals, alloys and magnets. The letter of intent also contemplates potential supply agree- ments pursuant to which Neo would purchase mixed rare earth carbonates, as well as neodymium and praseodymium oxides or metals from Molycorp, and a potential cooperative marketing and distribution


arrangement under which Neo would market various Molycorp products.


Furthermore, Molycorp, Inc., filed an amendment to its registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a propo- sed underwritten initial public offering of its com- mon stock. Molycorp proposes to sell 28,125,000 shares of common stock in the offering. Additionally, Molycorp will grant the underwriters an option to purchase up to 4,218,750 shares of common stock to cover over-allotments, if any. The estimated price range for the initial public offering is $15.00 to $17.00 per share. http://www.neomaterials.com


http://www.molycorp.com N


anoGram Corporation, a nanotechnology-based company based in California and partly ow-


ned by German venture capital company Nanostart, has been acquired by Teijin Limited (Tokyo Stock Exchange: 3401). This trade sale of its shareholding in NanoGram to Teijin marks the second exit so far this year for Nanostart. Earlier this year, the Swiss pharmaceutical giant Roche Diagnostics acquired the primary product line of another U.S.-based Nanostart portfolio company, BioMicro Systems Inc., in an asset sale transaction. http://www.nanogram.com


http://www.nanostart.de T


he United States National Science Foundation has awarded NanoMech, Inc. a Phase 1 grant


focused on applying NanoMech‘s proprietary and patent-pending nanotechnology innovations to


29


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83